Security key
230770109
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 5,430,722
- Share change
- +9,435
- Total reported value
- $40,086,000
- Price per share
- $7.36
- Number of holders
- 31
- Value change
- +$84,326
- Number of buys
- 14
- Number of sells
- 11
Report period
Q4 2017
Institutions
31
Top holders
10
CPIX full security history
Newer quarter: Q1 2018
Previous quarter: Q3 2017
CUMBERLAND PHARMACEUTICALS INC SEC filings
CUMBERLAND PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 230770109
Recent filing periods:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13F
|
Company |
8.4%
|
1,272,191
|
$8,982,000 | — | 30 Sep 2017 | |
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
5.9%
|
887,144
|
$6,263,000 | — | 30 Sep 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.8%
|
872,087
|
$6,157,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.6%
|
393,890
|
$2,781,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
316,005
|
$2,231,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
302,950
|
$2,139,000 | — | 30 Sep 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
283,700
|
$2,003,000 | — | 30 Sep 2017 | |
| JW Asset Management, LLC |
13F
|
Company |
1.8%
|
263,881
|
$1,863,000 | — | 30 Sep 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1.7%
|
250,230
|
$1,767,000 | — | 30 Sep 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.85%
|
128,427
|
$907,000 | — | 30 Sep 2017 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.59%
|
88,315
|
$624,000 | — | 30 Sep 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
53,800
|
$380,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.34%
|
50,760
|
$358,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
48,610
|
$343,000 | — | 30 Sep 2017 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.24%
|
36,626
|
$259,000 | — | 30 Sep 2017 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.23%
|
34,494
|
$244,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
24,264
|
$171,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
20,338
|
$143,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
20,053
|
$142,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.12%
|
18,405
|
$128,000 | — | 30 Sep 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.1%
|
14,900
|
$105,000 | — | 30 Sep 2017 | |
| DELTA ASSET MANAGEMENT LLC/TN |
13F
|
Company |
0.08%
|
12,000
|
$85,000 | — | 30 Sep 2017 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$71,000 | — | 30 Sep 2017 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$37,000 | — | 30 Sep 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.03%
|
3,851
|
$27,000 | — | 30 Sep 2017 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$21,000 | — | 30 Sep 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.02%
|
2,357
|
$17,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,071
|
$15,000 | — | 30 Sep 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.01%
|
1,114
|
$8,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
434
|
$3,000 | — | 30 Sep 2017 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
230
|
$2,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
89
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q4 2017
As of 31 Dec 2017,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,430,722 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, ARIEL INVESTMENTS, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, BRIDGEWAY CAPITAL MANAGEMENT INC, JW Asset Management, LLC, NEW YORK STATE COMMON RETIREMENT FUND, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
30
Q4 2017 holders
31
Holder diff
1
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.